Are amyloids infectious?

Current Hypotheses and Research Milestones in Alzheimer's Disease

Volumn , Issue , 2009, Pages 171-180

  Morales, Rodrigo ^a   Chen, Baian ^a   Soto, Claudio ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900231735     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-87995-6_14     Document Type: Chapter

References (56)

1. Soto C (2001) Protein misfolding and disease; protein refolding and therapy. FEBS Lett 498: 204-207
2. Chiti F and Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333-366
3. Carrell RW (2005) Cell toxicity and conformational disease. Trends Cell Biol 15: 574-580
4. Soto C, Estrada L, Castilla J (2006) Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem Sci 31: 150-155
5. Walker LC, Levine H III, Mattson MP, Jucker M (2006) Inducible proteopathies. Trends Neurosci 29: 438-443
6. Soto C (2003) Unfolding the role of protein misfolding in neurodegenerative diseases. Nature Rev Neurosci 4: 49-60
7. Glenner GG (1980) Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med 302: 1283-1292
8. Blake CC, Serpell LC, Sunde M, Sandgren O, Lundgren E (1996) A molecular model of the amyloid fibril. Ciba Found Symp 199: 6-15
9. Hardy J, Gwinn-Hardy K (1998) Genetic classification of primary neurodegenerative disease. Science 282: 1075-1079
10. Rockenstein E, Crews L, Masliah E (2007) Transgenic animal models of neurodegenerative diseases and their application to treatment development. Adv Drug Deliv Rev 59: 1093-1102
11. Canevari L, Abramov AY, Duchen MR (2004) Toxicity of amyloid beta peptide: Tales of calcium, mitochondria, and oxidative stress. Neurochem Res 29: 637-650
12. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101-112
13. Glabe CG (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 27: 570-557
14. Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26: 267-298
15. Collinge J (2001) Prion diseases of humans and animals: Their causes and molecular basis. Annu Rev Neurosci 24: 519-550
16. Cullie J, Chelle PL (1939) Experimental transmission of trembling to the goat. Comptes Rendus des Seances de l'Academie des Sciences 208: 1058-1160
17. Aguzzi A, Polymenidou M (2004) Mammalian prion biology: One century of evolving concepts. Cell 116: 313-327
18. Soto C, Castilla J (2004) The controversial protein-only hypothesis of prion propagation. Nat Med 10: S63-S67
19. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95: 13363-13383
20. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144
21. Bueler H, Aguzzi A, Sailer A,. et al. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73: 1339-1347
22. Fischer M, Rülicke T, Raeber A,. et al. (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15: 1255-1264
23. Groschup MH, Buschmann A (2008) Rodent models for prion diseases. Vet Res 39: 32.
24. Caughey B (2003) Prion protein conversions: Insight into mechanisms, TSE transmission barriers and strains. Br Med Bull 66: 109-120
25. Soto C, Saborio GP, Anderes L (2002) Cyclic amplification of protein misfolding: Application to prion-related disorders and beyond. Trends Neurosci 25: 390-394
26. Legname G, Baskakov IV, Nguyen HO,. et al. (2004) Synthetic mammalian prions. Science 305: 673-676
27. Saborio GP, Permanne B, Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411: 810-813
28. Castilla J, Saá P, Hetz C, Soto C (2005) In vitro generation of infectious scrapie prions. Cell 121: 195-206
29. Jarrett JT, Lansbury PT Jr (1993) Seeding 'one-dimensional crystallization' of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055-1058
30. Walker LC, Bian F, Callahan MJ,. et al. (2002) Modeling Alzheimer's disease and other proteopathies in vivo: Is seeding the key? Amino Acids 23: 87-93
31. Gajdusek DC (1994) Nucleation of amyloidogenesis in infectious and noninfectious amyloidoses of brain. Ann NY Acad Sci 724: 173-190
32. Harper JD, Lansbury PT Jr (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66: 385-407
33. Krebs MR, Morozova-Roche LA, Daniel K, Robinson CV, Dobson CM (2004) Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci 13: 1933-1938
34. Gajdusek DC, Gibbs CJ, Alpers M (1966) Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 209: 794-796
35. Sigurdsson EM, Wisniewski T, Frangione B (2002) Infectivity of amyloid diseases. Trends Mol Med 8: 411-413
36. Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ (1994) Induction of beta (A4)-Amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol Neurobiol 8: 25-39
37. Goudsmit J, Morrow CH, Asher DM,. et al. (1980) Evidence for and against the transmissibility of Alzheimer disease. Neurology 30: 945-950
38. Morales R, Abid K, Soto C (2007) The prion strain phenomenon: Molecular basis and unprecedented features. Biochim Biophys Acta 1772: 681-691
39. Duff K (2001) Transgenic mouse models of Alzheimer's disease: Phenotype and mechanisms of pathogenesis. Biochem Soc Symp 67: 195-202.
40. Kane MD, Lipinski WJ, Callahan MJ,. et al. (2000) Evidence for seeding of beta-Amyloid by intracerebral infusion of Alzheimer brain extracts in beta-Amyloid precursor proteintransgenic mice. J Neurosci 20: 3606-3611
41. Walker LC, Callahan MJ, Bian F,. et al. (2002) Exogenous induction of cerebral betaamyloidosis in betaAPP-Transgenic mice. Peptides 23: 1241-1247
42. Meyer-Luehmann M, Coomaraswamy J, Bolmont T,. et al. (2006) Exogenous induction of cerebral beta-Amyloidogenesis is governed by agent and host. Science 313: 1781-1784
43. Sipe JD (2000) Serum amyloid A: From fibril to function. Current status. Amyloid 7: 10-12
44. Buxbaum JN (2004) The systemic amyloidoses. Curr Opin Rheumatol 16: 67-75
45. Anders RF, Natvig JB, Michaelsen TE, Husby G (1975) Isolation and characterization of amyloid-related serum protein SAA as a low molecular weight protein. Scand J Immunol 4: 397-401
46. De Beer FC, Mallya RK, Fagan EA, Lanham JG, Hughes GR, Pepys MB (1982) Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet 2: 231-234
47. Sipe JD, Colten HR, Goldberger G,. et al. (1985) Human serum amyloid A (SAA): Biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry 24: 2931-2936
48. Kisilevsky R, Boudreau L (1983) Kinetics of amyloid deposition. I. The effects of amyloidenhancing factor and splenectomy. Lab Invest 48: 53-59
49. Ganowiak K, Hultman P, Engstrom U, Gustavsson A, Westermark P (1994) Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-Amyloidosis in mice. Biochem Biophys Res Commun 199: 306-312
50. Lundmark K, Westermark GT, Nyström S, Murphy CL, Solomon A, Westermark P (2002) Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci USA 99: 6979-6984
51. Higuchi K, Naiki H, Kitagawa K,. et al. (1995) Apolipoprotein A-II gene and development of amyloidosis and senescence in a congenic strain of mice carrying amyloidogenic ApoA-II. Lab Invest 72: 75-82
52. Higuchi K, Naiki H, Kitagawa K, Hosokawa M, Takeda T (1991) Mouse senile amyloidosis. ASSAM amyloidosis in mice presents universally as a systemic age-Associated amyloidosis. Virchows Arch B Cell Pathol Incl Mol Pathol 60: 231-238
53. Xing Y, Higuchi K (2002) Amyloid fibril proteins. Mech Ageing Dev 123: 1625-1636
54. Higuchi K, Kogishi K, Wang J,. et al. (1998) Fibrilization in mouse senile amyloidosis is fibril conformation-dependent. Lab Invest 78: 1535-1542
55. Xing Y, Nakamura A, Chiba T,. et al. (2001) Transmission of mouse senile amyloidosis. Lab Invest 81: 493-499
56. Xing Y, Nakamura A, Korenaga T,. et al. (2002) Induction of protein conformational change in mouse senile amyloidosis. J Biol Chem 277: 33164-33169